SCHEMBL23934992

SCHEMBL23934992

COc1ccc2ncc3nc(Cc4noc(C)n4)[nH]c3c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
GABRA2 P47869 1/20 0.38
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LRRK2 Q5S007 4/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
F10 P00742 1/20 0.36
MTNR1A P48039 2/20 0.35
MTNR1B P49286 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NOS3 P29474 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18658680 0.82 LRRK2 (0.49) GRIN1GRIN2BLRRK2
SCHEMBL23934968 0.80 GABRA1 (0.39) GRIN1GRIN2BGABRA1GABRG2GABRB3
SCHEMBL23935066 0.73 GABRA1 (0.39) GRIN1GRIN2BGABRA1GABRG2GABRB3
SCHEMBL18606427 0.71 CCNC (0.38) GRIN1GRIN2BGABRA1GABRG2GABRB3
SCHEMBL23935171 0.69 KLK1 (0.41) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23935100 0.69 HPGDS (0.40) GRIN1GRIN2BLMNALRRK2MAPT
SCHEMBL18658935 0.67 LRRK2 (0.49) LRRK2
SCHEMBL18658940 0.67 GRIN2B (0.41) GRIN1GRIN2BLRRK2
SCHEMBL23935062 0.67 LRRK2 (0.36) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL30638198 0.67 LRRK2 (0.37) GRIN1GRIN2BLRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3350178-B1 NOVEL IMIDAZO [4,5-C]QUINOLINE AND IMIDAZO [4,5-C][1,5]NAPHTHYRIDINE DERIVATIVES AS LRRK2 INHIBITORS PFIZER (US) 2021-10-20 EP disclosed